Invention Grant
US09480726B2 Leukotoxin E/D as a new anti-inflammatory agent and microbicide 有权
白介素E / D作为新型抗炎剂和杀微生物剂

Leukotoxin E/D as a new anti-inflammatory agent and microbicide
Abstract:
The present invention relates to methods for preventing or treating Human Immunodeficiency Virus (HIV) infection, inflammatory conditions, and graft-versus-host-disease (GVHD) in a subject. Therapeutic compositions of the present invention comprise Leukocidin E (LukE) and/or D proteins or polypeptides. The invention further relates to methods of treating Staphylococcus aureus infection by administering a composition comprising a CCR5 antagonist or any molecule that blocks LukE/D interaction with CCR5+ cells in an amount effective to treat the S. aureus infection in the subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0